P24928 (RPB1_HUMAN) Homo sapiens (Human)

DNA-directed RNA polymerase II subunit RPB1 UniProtKBInterProSTRINGInteractive Modelling

1970 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

43 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
The structure of INTAC-PEC complex Heteromer
A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VM56; A0A8W4F9W9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O00267; P18615; P30153; P60899; P63272; P67775; Q5TA45; Q6P9B9; Q75QN2; Q8IXH7; Q8N201; Q8WX92; Q96HW7; Q9H0H0; Q9H3P2; Q9NV88; Q9NVH2; Q9UL03;
11-1864
99.1710×ZN;MN;MG;
Structure of the human Mediator-bound transcription pre-initiation complex Heteromer
A0JLT2; O15514; O43513; O60244; O75448; O75586; P13984; P18074; P19387; P19388; P19447; P20226; P29083; P29084; P30876; P32780; P35269; P36954; P50613; P51946; P51948; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13503; Q13888; Q13889; Q15528; Q6P2C8; Q6ZYL4; Q71SY5; Q92759; Q96G25; Q96HR3; Q96RN5; Q9BTT4; Q9BUE0; Q9H204; Q9H944; Q9NPJ6; Q9NVC6; Q9NWA0; Q9NX70; Q9P086; Q9ULK4; Q9Y2X0; Q9Y3C7;
10-1657
100.0MG; 16×ZN;SF4;
TFIID-based holo PIC on SCP promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
11-1487
100.017×ZN;SF4;MG;
p53-bound TFIID-based holo PIC on HDM2 promoter Heteromer
A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P21675; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;
11-1487
100.016×ZN;SF4;MG;
Human holo-PIC in the initial transcribing state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
10-1485
100.0MG; 11×ZN;
Human holo-PIC in the initial transcribing state (no IIS) Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
10-1485
100.0MG; 10×ZN;
Human core-PIC in the open state Heteromer
O15514; P13984; P19387; P19388; P20226; P23193; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403;
10-1485
100.0MG; 11×ZN;
Human holo-PIC in the closed state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
10-1485
100.0MG; 11×ZN;
Human holo-PIC in the open state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
10-1485
100.0MG; 11×ZN;
Human core-PIC in the initial transcribing state Heteromer
O15514; P13984; P19387; P19388; P20226; P23193; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403;
10-1485
100.0MG; 11×ZN;
Human core-PIC in the initial transcribing state (no IIS) Heteromer
O15514; P13984; P19387; P19388; P20226; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403;
10-1485
100.0MG; 11×ZN;
Human holo-PIC in the closed state Heteromer
O15514; P13984; P18074; P19387; P19388; P19447; P20226; P23193; P29083; P29084; P30876; P32780; P35269; P36954; P50613; P51946; P51948; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403; Q13888; Q13889; Q6ZYL4; Q92759;
10-1485
100MG; 17×ZN;SF4;
Human core-PIC in the closed state Heteromer
O15514; P13984; P19387; P19388; P20226; P23193; P29083; P29084; P30876; P35269; P36954; P52434; P52435; P52655; P52657; P53803; P61218; P62487; P62875; Q00403;
10-1485
100.0MG; 11×ZN;
Structure of the p53/RNA polymerase II assembly Heteromer
O15514; P04637; P19387; P19388; P30876; P36954; P52434; P52435; P53803; P61218; P62487; P62875;
19-1485
100MG;ZN;
RNA Pol II(G) Heteromer
O15514; P0CAP2; P19387; P19388; P30876; P36954; P52434; P52435; P53803; P61218; P62487; P62875;
364-1484
100.0ZN;
Influenza A/H7N9 polymerase in elongation state with continuous Pol II pS5 CTD peptide mimic bound … Heteromer
M9TI86; M9TLW3; X5F427;
1705-1729
1002KH;MG;
Influenza A/H7N9 polymerase in self-stalled pre-termination state, with Pol II pS5 CTD peptide mimi… Heteromer
M9TI86; M9TLW3; X5F427;
1705-1729
100.0POP;MG;
1918 H1N1 Viral polymerase heterotrimer in complex with 4 repeat serine-5 phosphorylated PolII pept… Heteromer
Q3HM39; Q3HM40; Q3HM41;
1713-1737
100
1918 H1N1 Viral polymerase heterotrimer in complex with 4 repeat serine-5 phosphorylated PolII pept… Heteromer
Q3HM39; Q3HM40; Q3HM41;
1713-1737
100
Influenza A/H7N9 polymerase in pre-initiation state, intermediate conformation (I) with PB2-C(I), E… Heteromer
M9TI86; M9TLW3; X5F427;
1699-1722
100
Influenza A/H7N9 polymerase in pre-initiation state with continuous Pol II pS5 CTD peptide mimic bo… Heteromer
M9TI86; M9TLW3; X5F427;
1699-1721
100
Influenza B polymerase with Pol II pSer5 CTD peptide mimic bound in site 2B Heteromer
Q5V8X3; Q5V8Y6; Q5V8Z9;
1713-1733
100
Bat influenza A/H17N10 polymerase bound to four heptad repeats of serine 5 phosphorylated Pol II CTD Heteromer
H6QM90; H6QM91; H6QM92;
1713-1727
100ZN; 15×PO4;
Crystal structure of SR-related and CTD-associated factor 4(SCAF4-CID)with peptide S2,S5p-CTD Heteromer
O95104;
1787-1800
100UNX;
Crystal structure of the SPOC domain of human PHF3 in complex with RNA polymerase II CTD diheptapep… Heteromer
Q92576;
1790-1802
100
TDRD3 complex Heteromer
Q9H7E2;
1804-1816
100
RPRD1B C-terminal interacting domain bound to a pThr4 CTD peptide Heteromer
Q9NQG5;
1793-1804
100
A mechanism for the activation of the influenza virus transcriptase Heteromer
Q9IMP3; Q9IMP4; Q9IMP5;
1716-1727
100MG;
CID of human RPRD1A in complex with a phosphorylated peptide from RPB1-CTD Heteromer
Q96P16;
1788-1798
100UNX;
Crystal structure of the SPOC domain of human PHF3 in complex with RNA polymerase II CTD diheptapep… Heteromer
Q92576;
1790-1800
100
Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the Carboxy… Heteromer
Q9UPN6;
1790-1799
100ACT;
Crystal structure of the SPOC domain of human PHF3 in complex with RNA polymerase II CTD diheptapep… Heteromer
Q92576;
1792-1801
100
Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the Carboxy… Heteromer
Q9UPN6;
1795-1803
100NH4;SO4;
Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the Carboxy… Heteromer
Q9UPN6;
1795-1803
100NH4;SO4;
Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the Carboxy… Heteromer
Q9UPN6;
1790-1798
100SO4;
Influenza B polymerase bound to four heptad repeats of serine 5 phosphorylated Pol II CTD Heteromer
Q5V8X3; Q5V8Y6; Q5V8Z9;
1719-1727
100
Influenza A/H7N9 polymerase in replicase-like conformation in pre-initiation state with Pol II pS5 … Heteromer
M9TI86; M9TLW3; X5F427;
1699-1707
100MG;
Crystal Structure of the first bromodomain of human BRD4 in complex with an acetylated POLR2A pepti… Heteromer
O60885;
773-780
100EDO;
Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the Carboxy… Heteromer
Q9UPN6;
1795-1802
100SO4;
Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the Carboxy… Heteromer
Q9UPN6;
1795-1802
100SO4;
Crystal structure of the SPOC domain of human SHARP (SPEN) in complex with RNA polymerase II CTD he… Heteromer
Q96T58;
1789-1794
100
CTD-specific phosphatase Scp1 in complex with peptide from C-terminal domain of RNA polymerase II Heteromer
Q9GZU7;
1798-1802
100MG;
CTD-specific phosphatase Scp1 in complex with peptide C-terminal domain of RNA polymerase II Heteromer
Q9GZU7;
1798-1802
100MG;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8was.1.5monomer0.8111-1487
ZN;MG;100.00

4 SWISS-MODEL models built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 27ycx.1.Nmonomer0.7511-562
ZN;99.29
Isoform 26o9l.1.Amonomer0.6810-562
MG;ZN;99.29
Isoform 28hkc.1.Dmonomer0.5316-557
27.76
Isoform 26pst.1.Hmonomer0.5121-550
34.21